Development of Novel Water-Soluble Phytostanol Analogs: Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4): Preclinical Pharmacology, Pharmacokinetics and Toxicology-Reference-Cited by-同舟云学术

Development of Novel Water-Soluble Phytostanol Analogs: Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4): Preclinical Pharmacology, Pharmacokinetics and Toxicology

Published:2006-06-07 Issue:3 Volume:21 Page:151-168
ISSN:0897-5957
Container-title:Cardiovascular Drug Reviews
language:en
Short-container-title:

Author:

Ng Agatha W. K.,Lukic Tatjana,Pritchard P. Haydn,Wasan Kishor M.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1527-3466.2003.tb00113.x/fullpdf

Reference67 articles.

1. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation;Aviram;Ann Nutr Metab,1993

2. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol;Becker;J Pediatr,1993

3. Long-term treatment of severe familial hypercholesterolemia in children: effects of sitosterol and bezafibrate;Becker;Pediatrics,1992

4. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters;Berge;Science,2000

5. Incorporation of liposomal phytosterols into human cells in culture: A potential in vitro model for investigating pathological effects of phytosterolemia;Bhadra;Biochem Med Met Biol,1991

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Challenges in Plant Sterol Research: Fundamentals, Analysis, Applications and Production;Molecules;2023-09-08

2. The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells;Lipids in Health and Disease;2014-10-01

3. Effects of Monoglycerides on P-Glycoprotein: Modulation of the Activity and Expression in Caco-2 Cell Monolayers;Molecular Pharmaceutics;2008-07-24

4. The Treatment of Dyslipidemia—What's Left in the Pipeline?;ChemMedChem;2008-02-15

5. Lanthanide containing compounds for therapeutic care in bone resorption disorders;Dalton Transactions;2007